Alnylam Pharmaceuticals, Inc.;Icahn School of Medicine at Mount Sinai
发明人:
BETTENCOURT, Brian,FITZGERALD, Kevin,QUERBES, William,YASUDA, Makiko,DESNICK, Robert, J.
申请号：
LT13721433
公开号：
LT2836595T
申请日:
2013.04.10
申请国别(地区):
LT
年份:
2017
代理人:
摘要：
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ALAS1 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of ALAS1.
